NEW YORK, NY / ACCESSWIRE / February 3, 2022 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Revance Therapeutics, Inc. (NASDAQ:RVNC)
Class Period: November 25, 2019 - October 11, 2021
Lead Plaintiff Deadline: February 8, 2022
The RVNC lawsuit alleges that throughout the class period, Revance Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) quality control deficiencies existed at the Company's manufacturing facility for DaxibotulinumtoxinA for Injection ("DAXI"); (ii) the foregoing deficiencies decreased the likelihood that the Food and Drug Administration ("FDA") would approve the DAXI Biologics License Application ("BLA") in its current form; (iii) accordingly, it was unlikely that the DAXI BLA would obtain FDA approval within the timeframe the Company had represented to investors; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
Learn about your recoverable losses in RVNC: https://www.kleinstocklaw.com/pslra-1/revance-therapeutics-inc-loss-submission-form?id=23309&from=1
First Solar, Inc. (NASDAQ:FSLR)
This lawsuit is on behalf of all persons or entities that purchased or otherwise acquired shares of First Solar common stock between February 22, 2019, and February 20, 2020, inclusive.
Lead Plaintiff Deadline: March 8, 2022
According to the filed complaint, defendants made repeated misrepresentations to investors regarding the development of First Solar's newest "Series 6" solar module, the cost per unit it could achieve with that module, and the impact the changeover to this new product would have on the viability of its other business segments. As a result of defendants' misrepresentations, First Solar common stock traded at artificially inflated prices during the class period.
Learn about your recoverable losses in FSLR: https://www.kleinstocklaw.com/pslra-1/first-solar-inc-loss-submission-form?id=23309&from=1
Talkspace, Inc. f/k/a Hudson Executive Investment Corporation (NASDAQ:TALK)
This lawsuit is on behalf of: (a) all persons or entities that purchased or otherwise acquired Talkspace securities between June 11, 2020 and November 15, 2021, both dates inclusive, and/or (b) all holders of Talkspace common stock as of the record date for the special meeting of shareholders held on June 17, 2021.
Lead Plaintiff Deadline: March 8, 2022
Talkspace, Inc. f/k/a Hudson Executive Investment Corporation allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Hudson Executive Investment Corporation ("HEIC") had overstated its competitive advantage and due diligence capabilities with respect to identifying and effectuating a merger with target companies; (ii) HEIC had conducted inadequate due diligence into then-private, pre-Merger Talkspace, or else ignored and/or failed to disclose multiple red flags concerning then-private, pre-Merger Talkspace's business and operations; (iii) Talkspace was experiencing significantly increased online advertising costs in its B2C business since the beginning of 2021; (iv) Talkspace was experiencing lower conversion rates in its online advertising in its business-to-consumer ("B2C") business; (v) as a result of (iii) and (iv) above, Talkspace was experiencing increased customer acquisition costs and more tepid B2C demand than represented to investors; (vi) as a result of (iii)-(v) above, Talkspace was suffering from ballooning customer acquisition costs and worsening growth and gross margin trends; (vii) Talkspace had overvalued its accounts receivables from certain of its health plan clients in its B2B business, which amounts required adjustment downward; and (viii) as a result of (iii)-(vii) above, Talkspace's 2021 financial guidance was not achievable and lacked any reasonable basis in fact.
Learn about your recoverable losses in TALK: https://www.kleinstocklaw.com/pslra-1/talkspace-inc-f-k-a-hudson-executive-investment-corporation-loss-submission-form?id=23309&from=1
Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
[email protected]
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com
SOURCE: The Klein Law Firm